Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells

Heng-Wei Hsu, Rosalia de Necochea-Campion, Vonetta Williams, Penelope J. Duerksen-Hughes, Alfred A. Simental Jr., Robert L. Ferris, Chien-Shing Chen, Saied Mirshahidi
  • Oral Oncology, July 2014, Elsevier
  • DOI: 10.1016/j.oraloncology.2014.03.006

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Penelope Duerksen-Hughes